Generation of a recombinant avian coronavirus infectious bronchitis virus using transient dominant selection.
Identifieur interne : 002992 ( PubMed/Curation ); précédent : 002991; suivant : 002993Generation of a recombinant avian coronavirus infectious bronchitis virus using transient dominant selection.
Auteurs : Paul Britton [Royaume-Uni] ; Sharon Evans ; Brian Dove ; Marc Davies ; Rosa Casais ; Dave CavanaghSource :
- Journal of virological methods [ 0166-0934 ] ; 2005.
Descripteurs français
- KwdFr :
- ADN complémentaire (génétique), ARN viral (analyse), Animaux, Assemblage viral, Glycoprotéine de spicule des coronavirus, Glycoprotéines membranaires (génétique), Glycoprotéines membranaires (physiologie), Infections à coronavirus (), Infections à coronavirus (anatomopathologie), Infections à coronavirus (médecine vétérinaire), Infections à coronavirus (virologie), Protéines de l'enveloppe virale (génétique), Protéines de l'enveloppe virale (physiologie), Recombinaison génétique, Techniques de culture d'organes, Virus de la bronchite infectieuse (génétique), Virus de la bronchite infectieuse (physiologie), Virus de la vaccine (génétique).
- MESH :
- analyse : ARN viral.
- anatomopathologie : Infections à coronavirus.
- génétique : ADN complémentaire, Glycoprotéines membranaires, Protéines de l'enveloppe virale, Virus de la bronchite infectieuse, Virus de la vaccine.
- médecine vétérinaire : Infections à coronavirus.
- physiologie : Glycoprotéines membranaires, Protéines de l'enveloppe virale, Virus de la bronchite infectieuse.
- virologie : Infections à coronavirus.
- Animaux, Assemblage viral, Glycoprotéine de spicule des coronavirus, Infections à coronavirus, Recombinaison génétique, Techniques de culture d'organes.
English descriptors
- KwdEn :
- Animals, Coronavirus Infections (pathology), Coronavirus Infections (prevention & control), Coronavirus Infections (veterinary), Coronavirus Infections (virology), DNA, Complementary (genetics), Infectious bronchitis virus (genetics), Infectious bronchitis virus (physiology), Membrane Glycoproteins (genetics), Membrane Glycoproteins (physiology), Organ Culture Techniques, RNA, Viral (analysis), Recombination, Genetic, Spike Glycoprotein, Coronavirus, Vaccinia virus (genetics), Viral Envelope Proteins (genetics), Viral Envelope Proteins (physiology), Virus Assembly.
- MESH :
- chemical , analysis : RNA, Viral.
- chemical , genetics : DNA, Complementary, Membrane Glycoproteins, Viral Envelope Proteins.
- genetics : Infectious bronchitis virus, Vaccinia virus.
- pathology : Coronavirus Infections.
- physiology : Infectious bronchitis virus, Membrane Glycoproteins, Viral Envelope Proteins.
- prevention & control : Coronavirus Infections.
- veterinary : Coronavirus Infections.
- virology : Coronavirus Infections.
- Animals, Organ Culture Techniques, Recombination, Genetic, Spike Glycoprotein, Coronavirus, Virus Assembly.
Abstract
A reverse genetics system for the avian coronavirus infectious bronchitis virus (IBV) has been described in which a full-length cDNA, corresponding to the IBV (Beaudette-CK) genome, was inserted into the vaccinia virus genome following in vitro assembly of three contiguous cDNAs [Casais, R., Thiel, V., Siddell, S.G., Cavanagh, D., Britton, P., 2001. Reverse genetics system for the avian coronavirus infectious bronchitis virus. J. Virol. 75, 12359-12369]. The method has subsequently been used to generate a recombinant IBV expressing a chimaeric S gene [Casais, R., Dove, B., Cavanagh, D., Britton, P., 2003. Recombinant avian infectious bronchitis virus expressing a heterologous spike gene demonstrates that the spike protein is a determinant of cell tropism. J. Virol. 77, 9084-9089]. Use of vaccinia virus as a vector for the full-length cDNA of the IBV genome has the advantage that modifications can be made to the IBV cDNA using homologous recombination, a method frequently used to insert and delete sequences from the vaccinia virus genome. We describe the use of homologous recombination as a method for modifying the Beaudette full-length cDNA, within the vaccinia virus genome, without the requirement for in vitro assembly of the IBV cDNA. To demonstrate the feasibility of the method we exchanged the ectodomain of the Beaudette spike gene for the corresponding region from IBV M41 and generated two recombinant infectious bronchitis viruses (rIBVs) expressing the chimaeric S protein, validating the method as an alternative way for generating rIBVs.
DOI: 10.1016/j.jviromet.2004.09.017
PubMed: 15620403
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002992
Links to Exploration step
pubmed:15620403Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Generation of a recombinant avian coronavirus infectious bronchitis virus using transient dominant selection.</title>
<author><name sortKey="Britton, Paul" sort="Britton, Paul" uniqKey="Britton P" first="Paul" last="Britton">Paul Britton</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Molecular Biology, Institute for Animal Health, Compton Laboratory, Compton, Newbury, Berkshire RG20 7NN, UK. paul.britton@bbsrc.ac.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Molecular Biology, Institute for Animal Health, Compton Laboratory, Compton, Newbury, Berkshire RG20 7NN</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Evans, Sharon" sort="Evans, Sharon" uniqKey="Evans S" first="Sharon" last="Evans">Sharon Evans</name>
</author>
<author><name sortKey="Dove, Brian" sort="Dove, Brian" uniqKey="Dove B" first="Brian" last="Dove">Brian Dove</name>
</author>
<author><name sortKey="Davies, Marc" sort="Davies, Marc" uniqKey="Davies M" first="Marc" last="Davies">Marc Davies</name>
</author>
<author><name sortKey="Casais, Rosa" sort="Casais, Rosa" uniqKey="Casais R" first="Rosa" last="Casais">Rosa Casais</name>
</author>
<author><name sortKey="Cavanagh, Dave" sort="Cavanagh, Dave" uniqKey="Cavanagh D" first="Dave" last="Cavanagh">Dave Cavanagh</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15620403</idno>
<idno type="pmid">15620403</idno>
<idno type="doi">10.1016/j.jviromet.2004.09.017</idno>
<idno type="wicri:Area/PubMed/Corpus">002992</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002992</idno>
<idno type="wicri:Area/PubMed/Curation">002992</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002992</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Generation of a recombinant avian coronavirus infectious bronchitis virus using transient dominant selection.</title>
<author><name sortKey="Britton, Paul" sort="Britton, Paul" uniqKey="Britton P" first="Paul" last="Britton">Paul Britton</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Molecular Biology, Institute for Animal Health, Compton Laboratory, Compton, Newbury, Berkshire RG20 7NN, UK. paul.britton@bbsrc.ac.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Molecular Biology, Institute for Animal Health, Compton Laboratory, Compton, Newbury, Berkshire RG20 7NN</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Evans, Sharon" sort="Evans, Sharon" uniqKey="Evans S" first="Sharon" last="Evans">Sharon Evans</name>
</author>
<author><name sortKey="Dove, Brian" sort="Dove, Brian" uniqKey="Dove B" first="Brian" last="Dove">Brian Dove</name>
</author>
<author><name sortKey="Davies, Marc" sort="Davies, Marc" uniqKey="Davies M" first="Marc" last="Davies">Marc Davies</name>
</author>
<author><name sortKey="Casais, Rosa" sort="Casais, Rosa" uniqKey="Casais R" first="Rosa" last="Casais">Rosa Casais</name>
</author>
<author><name sortKey="Cavanagh, Dave" sort="Cavanagh, Dave" uniqKey="Cavanagh D" first="Dave" last="Cavanagh">Dave Cavanagh</name>
</author>
</analytic>
<series><title level="j">Journal of virological methods</title>
<idno type="ISSN">0166-0934</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Coronavirus Infections (pathology)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Coronavirus Infections (veterinary)</term>
<term>Coronavirus Infections (virology)</term>
<term>DNA, Complementary (genetics)</term>
<term>Infectious bronchitis virus (genetics)</term>
<term>Infectious bronchitis virus (physiology)</term>
<term>Membrane Glycoproteins (genetics)</term>
<term>Membrane Glycoproteins (physiology)</term>
<term>Organ Culture Techniques</term>
<term>RNA, Viral (analysis)</term>
<term>Recombination, Genetic</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Vaccinia virus (genetics)</term>
<term>Viral Envelope Proteins (genetics)</term>
<term>Viral Envelope Proteins (physiology)</term>
<term>Virus Assembly</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ADN complémentaire (génétique)</term>
<term>ARN viral (analyse)</term>
<term>Animaux</term>
<term>Assemblage viral</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires (génétique)</term>
<term>Glycoprotéines membranaires (physiologie)</term>
<term>Infections à coronavirus ()</term>
<term>Infections à coronavirus (anatomopathologie)</term>
<term>Infections à coronavirus (médecine vétérinaire)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Protéines de l'enveloppe virale (génétique)</term>
<term>Protéines de l'enveloppe virale (physiologie)</term>
<term>Recombinaison génétique</term>
<term>Techniques de culture d'organes</term>
<term>Virus de la bronchite infectieuse (génétique)</term>
<term>Virus de la bronchite infectieuse (physiologie)</term>
<term>Virus de la vaccine (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>RNA, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>DNA, Complementary</term>
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>ARN viral</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Infectious bronchitis virus</term>
<term>Vaccinia virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>ADN complémentaire</term>
<term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Virus de la bronchite infectieuse</term>
<term>Virus de la vaccine</term>
</keywords>
<keywords scheme="MESH" qualifier="médecine vétérinaire" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Virus de la bronchite infectieuse</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Infectious bronchitis virus</term>
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="veterinary" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Organ Culture Techniques</term>
<term>Recombination, Genetic</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Virus Assembly</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Assemblage viral</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Infections à coronavirus</term>
<term>Recombinaison génétique</term>
<term>Techniques de culture d'organes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A reverse genetics system for the avian coronavirus infectious bronchitis virus (IBV) has been described in which a full-length cDNA, corresponding to the IBV (Beaudette-CK) genome, was inserted into the vaccinia virus genome following in vitro assembly of three contiguous cDNAs [Casais, R., Thiel, V., Siddell, S.G., Cavanagh, D., Britton, P., 2001. Reverse genetics system for the avian coronavirus infectious bronchitis virus. J. Virol. 75, 12359-12369]. The method has subsequently been used to generate a recombinant IBV expressing a chimaeric S gene [Casais, R., Dove, B., Cavanagh, D., Britton, P., 2003. Recombinant avian infectious bronchitis virus expressing a heterologous spike gene demonstrates that the spike protein is a determinant of cell tropism. J. Virol. 77, 9084-9089]. Use of vaccinia virus as a vector for the full-length cDNA of the IBV genome has the advantage that modifications can be made to the IBV cDNA using homologous recombination, a method frequently used to insert and delete sequences from the vaccinia virus genome. We describe the use of homologous recombination as a method for modifying the Beaudette full-length cDNA, within the vaccinia virus genome, without the requirement for in vitro assembly of the IBV cDNA. To demonstrate the feasibility of the method we exchanged the ectodomain of the Beaudette spike gene for the corresponding region from IBV M41 and generated two recombinant infectious bronchitis viruses (rIBVs) expressing the chimaeric S protein, validating the method as an alternative way for generating rIBVs.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15620403</PMID>
<DateCompleted><Year>2005</Year>
<Month>04</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0166-0934</ISSN>
<JournalIssue CitedMedium="Print"><Volume>123</Volume>
<Issue>2</Issue>
<PubDate><Year>2005</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virological methods</Title>
<ISOAbbreviation>J. Virol. Methods</ISOAbbreviation>
</Journal>
<ArticleTitle>Generation of a recombinant avian coronavirus infectious bronchitis virus using transient dominant selection.</ArticleTitle>
<Pagination><MedlinePgn>203-11</MedlinePgn>
</Pagination>
<Abstract><AbstractText>A reverse genetics system for the avian coronavirus infectious bronchitis virus (IBV) has been described in which a full-length cDNA, corresponding to the IBV (Beaudette-CK) genome, was inserted into the vaccinia virus genome following in vitro assembly of three contiguous cDNAs [Casais, R., Thiel, V., Siddell, S.G., Cavanagh, D., Britton, P., 2001. Reverse genetics system for the avian coronavirus infectious bronchitis virus. J. Virol. 75, 12359-12369]. The method has subsequently been used to generate a recombinant IBV expressing a chimaeric S gene [Casais, R., Dove, B., Cavanagh, D., Britton, P., 2003. Recombinant avian infectious bronchitis virus expressing a heterologous spike gene demonstrates that the spike protein is a determinant of cell tropism. J. Virol. 77, 9084-9089]. Use of vaccinia virus as a vector for the full-length cDNA of the IBV genome has the advantage that modifications can be made to the IBV cDNA using homologous recombination, a method frequently used to insert and delete sequences from the vaccinia virus genome. We describe the use of homologous recombination as a method for modifying the Beaudette full-length cDNA, within the vaccinia virus genome, without the requirement for in vitro assembly of the IBV cDNA. To demonstrate the feasibility of the method we exchanged the ectodomain of the Beaudette spike gene for the corresponding region from IBV M41 and generated two recombinant infectious bronchitis viruses (rIBVs) expressing the chimaeric S protein, validating the method as an alternative way for generating rIBVs.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Britton</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Division of Molecular Biology, Institute for Animal Health, Compton Laboratory, Compton, Newbury, Berkshire RG20 7NN, UK. paul.britton@bbsrc.ac.uk</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Evans</LastName>
<ForeName>Sharon</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Dove</LastName>
<ForeName>Brian</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y"><LastName>Davies</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Casais</LastName>
<ForeName>Rosa</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cavanagh</LastName>
<ForeName>Dave</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>J Virol Methods</MedlineTA>
<NlmUniqueID>8005839</NlmUniqueID>
<ISSNLinking>0166-0934</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018076">DNA, Complementary</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578553">MHV surface projection glycoprotein</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578557">spike glycoprotein, SARS-CoV</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001351" MajorTopicYN="N">Infectious bronchitis virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009924" MajorTopicYN="N">Organ Culture Techniques</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011995" MajorTopicYN="Y">Recombination, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014616" MajorTopicYN="N">Vaccinia virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019065" MajorTopicYN="N">Virus Assembly</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year>
<Month>07</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2004</Year>
<Month>09</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2004</Year>
<Month>09</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>12</Month>
<Day>29</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>4</Month>
<Day>2</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>12</Month>
<Day>29</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15620403</ArticleId>
<ArticleId IdType="pii">S0166-0934(04)00303-9</ArticleId>
<ArticleId IdType="doi">10.1016/j.jviromet.2004.09.017</ArticleId>
<ArticleId IdType="pmc">PMC7112893</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Gen Virol. 2001 Jun;82(Pt 6):1273-1281</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11369870</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2003 Aug;77(16):9084-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12885925</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nucleic Acids Res. 1995 Dec 25;23(24):4992-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8559656</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):12989-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9789028</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2001 Jan;75(1):506-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11119619</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1981 Apr;78(4):2072-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7017722</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Avian Pathol. 2001 Aug;30(4):423-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19184927</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2000 Feb;74(3):1566-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10627571</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12995-3000</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14569023</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2000 Mar;81(Pt 3):791-801</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10675417</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1989 Jul;171(1):189-204</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2525837</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1994 Sep;203(2):286-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8053152</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2000 Dec;81(Pt 12):2855-2865</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11086116</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1990 Jun;64(6):3108-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2159565</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1995 Jul 10;210(2):383-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7618275</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Adv Virus Res. 1997;48:1-100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9233431</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 1996 May;77 ( Pt 5):963-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8609493</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Avian Pathol. 2001 Aug;30(4):355-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19184921</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>New Biol. 1989 Dec;1(3):285-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2487295</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Jan;72(1):170-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9420213</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Avian Pathol. 2001 Apr;30(2):109-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19184884</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2000 May 9;97(10):5516-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10805807</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2002 Nov;76(21):11065-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12368349</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2001 Dec;75(24):12359-69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11711626</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1994 Feb;198(2):415-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8291226</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):991-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9023370</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 1981 Nov 20;214(4523):916-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6272391</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virus Res. 1986 Feb;4(2):133-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3010595</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1996 Dec;70(12):8660-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8970992</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1992 Sep;66(9):5425-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1501281</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Avian Pathol. 2002 Feb;31(1):81-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12425795</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2000 Nov;74(22):10600-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11044104</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Arch Virol. 1979;61(3):227-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">227344</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1987 Dec;61(12):3809-19</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3479621</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2001 Feb 1;280(1):87-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11162822</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 1987 Jan;68 ( Pt 1):57-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3027249</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002992 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002992 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:15620403 |texte= Generation of a recombinant avian coronavirus infectious bronchitis virus using transient dominant selection. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:15620403" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |